Cargando…

Use of aripiprazole in dysthymic disorders. Purposely a case

INTRODUCTION: Dysthymia is a chronic mood disorder with similar but less severe features than major depressive disorder. Compared to the latter, major depressive episodes of dysthymic disorder are more spaced, less intense, and more persistent. The most effective treatment is usually the combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogando Portilla, N., Bañon Gonzalez, S. M., Agudo Urbanos, M., Martinez Cortes, M., Sobrino Cabra, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479158/
http://dx.doi.org/10.1192/j.eurpsy.2023.1778
_version_ 1785101515018469376
author Ogando Portilla, N.
Bañon Gonzalez, S. M.
Agudo Urbanos, M.
Martinez Cortes, M.
Sobrino Cabra, O.
author_facet Ogando Portilla, N.
Bañon Gonzalez, S. M.
Agudo Urbanos, M.
Martinez Cortes, M.
Sobrino Cabra, O.
author_sort Ogando Portilla, N.
collection PubMed
description INTRODUCTION: Dysthymia is a chronic mood disorder with similar but less severe features than major depressive disorder. Compared to the latter, major depressive episodes of dysthymic disorder are more spaced, less intense, and more persistent. The most effective treatment is usually the combination of serotonin reuptake inhibitor antidepressant drugs with behavioral, cognitive, interpersonal and group psychotherapies. The reality is that there are few clearly effective treatments to treat this disorder which makes the symptoms even more chronic which has a negative impact on the functionality of patients with clear influence at a personal and work level. Without treatment, dysthymia sometimes progresses to major depression, called “double depression” what can be a most serious problem. OBJECTIVES: Finding new lines of treatment or management in these patients seems to be essential because of the inability that can occur in some of them and the high demand they can produce. METHODS: A 45-year-old woman diagnosed of dysthymia has been followed for more than 10 years. Multiple visits to the emergency room and several outpatient mental health services. absenteeism and great repercussion in the family environment. Many side effects to antidepressants and a benzodiazepine overuse tendency. She has been receiving psychotherapeutic treatment for many years with little effectiveness. Worsening of the symptoms with the appearance of obsessiveness around what is happening to her RESULTS: Several alternative treatments are tested for the management of anxious depressive and obsessive symptoms being Aripiprazole 10mg the only effective one with almost complete recovery of symptoms. The patient returns to work and significantly improves her family situation. CONCLUSIONS: Dysthyma is a disorder with difficult pharmacological and psychological management. Trying different little-used treatments can open up a different view about the disorder. The use of serotonin reuptake inhibitor antidepressant drugs is not always effective and the risk posed by using benzodiazepines for long time forces us to look for other treatments for the control of the main symptoms The use of aripiprazole at moderate doses may be a good new way to control symptoms. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10479158
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104791582023-09-06 Use of aripiprazole in dysthymic disorders. Purposely a case Ogando Portilla, N. Bañon Gonzalez, S. M. Agudo Urbanos, M. Martinez Cortes, M. Sobrino Cabra, O. Eur Psychiatry Abstract INTRODUCTION: Dysthymia is a chronic mood disorder with similar but less severe features than major depressive disorder. Compared to the latter, major depressive episodes of dysthymic disorder are more spaced, less intense, and more persistent. The most effective treatment is usually the combination of serotonin reuptake inhibitor antidepressant drugs with behavioral, cognitive, interpersonal and group psychotherapies. The reality is that there are few clearly effective treatments to treat this disorder which makes the symptoms even more chronic which has a negative impact on the functionality of patients with clear influence at a personal and work level. Without treatment, dysthymia sometimes progresses to major depression, called “double depression” what can be a most serious problem. OBJECTIVES: Finding new lines of treatment or management in these patients seems to be essential because of the inability that can occur in some of them and the high demand they can produce. METHODS: A 45-year-old woman diagnosed of dysthymia has been followed for more than 10 years. Multiple visits to the emergency room and several outpatient mental health services. absenteeism and great repercussion in the family environment. Many side effects to antidepressants and a benzodiazepine overuse tendency. She has been receiving psychotherapeutic treatment for many years with little effectiveness. Worsening of the symptoms with the appearance of obsessiveness around what is happening to her RESULTS: Several alternative treatments are tested for the management of anxious depressive and obsessive symptoms being Aripiprazole 10mg the only effective one with almost complete recovery of symptoms. The patient returns to work and significantly improves her family situation. CONCLUSIONS: Dysthyma is a disorder with difficult pharmacological and psychological management. Trying different little-used treatments can open up a different view about the disorder. The use of serotonin reuptake inhibitor antidepressant drugs is not always effective and the risk posed by using benzodiazepines for long time forces us to look for other treatments for the control of the main symptoms The use of aripiprazole at moderate doses may be a good new way to control symptoms. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10479158/ http://dx.doi.org/10.1192/j.eurpsy.2023.1778 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Ogando Portilla, N.
Bañon Gonzalez, S. M.
Agudo Urbanos, M.
Martinez Cortes, M.
Sobrino Cabra, O.
Use of aripiprazole in dysthymic disorders. Purposely a case
title Use of aripiprazole in dysthymic disorders. Purposely a case
title_full Use of aripiprazole in dysthymic disorders. Purposely a case
title_fullStr Use of aripiprazole in dysthymic disorders. Purposely a case
title_full_unstemmed Use of aripiprazole in dysthymic disorders. Purposely a case
title_short Use of aripiprazole in dysthymic disorders. Purposely a case
title_sort use of aripiprazole in dysthymic disorders. purposely a case
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479158/
http://dx.doi.org/10.1192/j.eurpsy.2023.1778
work_keys_str_mv AT ogandoportillan useofaripiprazoleindysthymicdisorderspurposelyacase
AT banongonzalezsm useofaripiprazoleindysthymicdisorderspurposelyacase
AT agudourbanosm useofaripiprazoleindysthymicdisorderspurposelyacase
AT martinezcortesm useofaripiprazoleindysthymicdisorderspurposelyacase
AT sobrinocabrao useofaripiprazoleindysthymicdisorderspurposelyacase